江苏爱朋医疗科技股份有限公司的主营业务是疼痛管理、鼻腔及上气道管理细分领域用医疗器械研发、 生产、销售。公司的主要产品是疼痛管理产品、鼻腔及上气道产品。诺斯清鼻腔护理产品连续9年蝉联 天猫、京东双平台洗鼻器类销量双冠军，诺斯清品牌也斩获备受瞩目的"西湖奖·创新营销"奖项，并二 次蝉联"西湖奖·最受药店欢迎的明星单品"殊荣，2024米思会-中国医药健康产业共生大会获"中国连锁药 店最具合作价值单品"。报告期内，凭借在鼻腔护理领域的深厚积累，"诺斯清"品牌成功入选上海市重 点商标保护名录。 最新一期业绩显示，2025年一季报，公司实现营业收入6482.19万元，同比-26.13%；净利 润-17649164.17元，同比-1400.65%，销售毛利率61.91%。 6月5日，爱朋医疗今日收盘24.88元，下跌2.43%，最新市净率4.60，总市值31.36亿元。 股东方面，截至2025年3月31日，爱朋医疗股东户数20629户，较上次增加1752户，户均持股市值35.28 万元，户均持股数量2.76万股。 序号股票简称PE(TTM)PE(静)市净率总市值(元)4爱朋医疗-382.20290.364.6031.36 ...

Core Viewpoint - The increasing emphasis on investor relations management by listed companies in China's capital market is highlighted, with shareholder return activities becoming a focal point of market attention [1]. Group 1: Shareholder Return Activities - As of May 16, 2023, eight A-share listed companies have conducted shareholder return activities this year [2]. - Anhui Yingjia Distillery Co., Ltd. announced a "10th Anniversary Shareholder Return" event, offering limited edition commemorative liquor at a discounted price for shareholders [2]. - Shede Distillery Co., Ltd. is also providing discounts on commemorative liquor for shareholders as part of its "2025 Shareholder Return" initiative [2]. Group 2: Continuous Engagement - Jiangsu Aipeng Medical Technology Co., Ltd. has been conducting shareholder return activities for four consecutive years, offering free health products to shareholders [3]. - Hainan Strait Shipping Co., Ltd. has also been engaging in shareholder return activities for multiple years, providing discounted tickets for shareholders and their friends [3]. Group 3: Future Trends - Experts suggest that shareholder return activities are likely to become a regular practice among listed companies, with a focus on innovation in form and content [3]. - Companies are expected to design more personalized and diversified return activities based on strategic positioning, product characteristics, and shareholder needs [3].

4月3日，爱朋医疗今日收盘23.56元，下跌3.28%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到561.71倍，总市值29.70亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均46.48倍，行业中值31.96倍，爱朋医疗排 名第120位。 江苏爱朋医疗科技股份有限公司的主营业务是疼痛管理、鼻腔及上气道管理细分领域用医疗器械研发、 生产、销售以及相关医疗器械CXO服务，主要产品包括微电脑注药泵、无线镇痛管理系统、麻醉深度 监测仪、高渗缓冲海水鼻腔护理喷雾器、弱酸性缓冲生理海水鼻腔护理喷雾器、"敏伴"复合益生菌粉固 体饮料、安波澜便携多导睡眠记录系统、医疗器械设备CXO。报告期内，诺斯清品牌获乌镇健康大 会"西湖奖·创新营销"奖项，并二次蝉联"西湖奖·最受药店欢迎的明星单品"。诺斯清产品再获2024米思 会-中国医药健康产业共生大会"中国连锁药店最具合作价值单品"。 最新一期业绩显示，2024年三季报，公司实现营业收入2.75亿元，同比-7.12%；净利润380.73万元，同 比-43.99%，销售毛利率69.02%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)120 ...